Royal Bank of Canada
VIE

Royal Bank of Canada’s Viela Bio, Inc. Common Stock VIE Stock Holding History

Royal Bank of Canada’s Portfolio VIE Stock Details VIE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9
Closed – – 7467
2020
Q3 		$0 Buy
9
+5
+125% +$177 ﹤0.01% 7183
2020
Q2 		$0 Sell
4
-176
-98% -$7.97K ﹤0.01% 7104
2020
Q1 		$7K Sell
180
-223
-55% -$8.69K ﹤0.01% 5960
2019
Q4 		$11K Buy
+403
New +$10.2K ﹤0.01% 6128

Other funds holding VIE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada's VIE Position: Q4 2020 in Review

Royal Bank of Canada sold out of Viela Bio, Inc. Common Stock (VIE) in Q4 2020, closing a stake of 9 shares.

Royal Bank of Canada first reported a position in VIE in Q4 2019 and held it in 4 quarters. The position peaked at $11K in Q4 2019. 65 funds tracked by Wall St. Rank hold VIE as of Q4 2020.

  • Royal Bank of Canada reported no remaining Viela Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 9 Viela Bio, Inc. Common Stock shares in Q4 2020.
  • Royal Bank of Canada first reported a position in Viela Bio, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Royal Bank of Canada's Viela Bio, Inc. Common Stock position peaked at $11K in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Viela Bio, Inc. Common Stock as of Q4 2020.

Based on Royal Bank of Canada's 13F filing for Q4 2020, filed 16 Feb 2021.